// App-Quantinova.ai

13474 : PI3K? is Required for Recovery from Transient Cre/tamoxifen Induced Cardiotoxicity

Researchers

Presenter

  • Seyyed M. R. Kazemi-Bajestani

Principal Investigators

  • Zamaneh Kassiri

  • Bart Vanhaesebroeck

  • Gavin Y. Oudit

Medical Centers

  • Queen Mary University of London, London, United Kingdom

  • Univ. of Alberta, Edmonton, Alberta, Canada.

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Systolic dysfunction

  • Cardiotoxicity

  • Heart muscle disease

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Drug/Treatment

  • Phosphatidylinositol

  • Tamoxifen

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved